City of Hope Cancer Center Chicago Appoints Dr. Monica Malec as Chief of Supportive Care and Integrative Oncology

CHICAGO - DATE - City of Hope Cancer Center Chicago, part of one of the largest and most advanced cancer research and treatment organizations in the United States, has appointed Monica Malec, M.D., F.A.A.H.P., as chief of supportive care and integrative oncology for its Illinois locations. In this role, she will support the Chicago-area palliative and supportive care program, which addresses patients' physical, emotional and psychosocial needs across the cancer care continuum.

Dr. Malec has more than 30 years of experience in supportive and palliative medicine, along with more than two decades of academic and clinical leadership within leading Chicago-area health systems, including Rush University Medical Center and the University of Chicago. A physician-scholar and researcher, she has authored more than 30 peer-reviewed publications and has served as a co-investigator on multiple research initiatives.

"At City of Hope, we believe the best outcomes are achieved when supportive care is integrated into treatment plans and side effects are proactively and actively managed," said Pete Govorchin, president of City of Hope Cancer Center Chicago. "Dr. Malec's leadership will continue to build upon a strong supportive care foundation, further strengthening real-time collaboration with our multidisciplinary teams and ensuring our patients receive the most comprehensive and personalized support throughout their care."

In addition to her leadership role, Dr. Malec serves as an associate clinical professor in the department of medicine at City of Hope and provides clinical care to patients at all three Illinois locations: Zion, downtown Chicago and Morton Grove. Her clinical practice focuses on the management of complex cancer-related pain and other symptoms that are resistant to initial treatment, with a central goal of improving quality of life.

"City of Hope has long set the standard for what supportive and palliative care can - and should - be within oncology," said Dr. Malec. "The organization's unwavering focus on whole-person care mirrors my own commitment to improving quality of life for patients. By collaborating with national leaders across the City of Hope system, I look forward to expanding access to these essential services to every patient possible."

Dr. Malec is board certified in internal medicine as well as hospice and palliative medicine. She earned her medical degree from the University of Illinois at Chicago and completed her internal medicine residency at Rush University Medical Center.

###

About City of Hope
City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the United States, and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked among the nation's top cancer centers by U.S. News & World Report at its core, City of Hope's uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope's growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope's affiliated group of organizations includes Translational Genomics Research Institute and AccessHope^TM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.